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Objective. Coronary artery bypass grafting (CABG) represents the significant source of increased oxidative stress (OS). We aimed to
follow the OS status parameters (i.e., ischemia-modified albumin (IMA), malondialdehyde (MDA), superoxide anion, prooxidant-
antioxidant balance (PAB), total oxidant status (TOS), total antioxidant status (TAS), and superoxide-dismutase (SOD)) change
through the predefined study times in two different surgical procedures, i.e., cardiopulmonary bypass (CPB) and off-pump
coronary artery bypass grafting (OPCAB). Additionally, we aimed to investigate those OS status parameters in specific study
times according to SYNTAX score (SS), an established angiographic score for evaluating the extensity and severity of coronary
artery disease. Patients and Methods. A total of 107 patients that were planned to undergo CABG were included (i.e., 47 patients
in OPCAB and 60 patients in CPB group). Blood samples were taken at 6 time intervals: before surgery (t1), immediately after
intervention (t2), 6 h (t3), 24 h (t4), 48 h (t5), and 96 h after termination of the operation (t6). Results. IMA levels were higher in
CPB than that in OPCAB baseline and rose in CPB group in t2 point. TOS decreased in both study groups, compared to
baseline values, but without statistical significance. Superoxide anion and PAB significantly increased in t3-t6 study times, in
both groups. MDA significantly increased only in CPB group in t5 and t6 interval. MDA was significantly higher in CPB group
compared to OPCAB in t6 study point. CPB patients had significantly lower TAS compared to OPCAB patients at the
beginning and in t2 and t3 study points. They also had significantly lower SOD activities compared to OPCAB, baseline, and in
several study points. Moreover, TAS, SOD, and TAS/TOS ratio were significantly lower, whereas PAB and TOS/TAS were
significantly higher in patients with high SS compared to corresponding groups. SOD activity, IMA, and TAS level were the best
predictors of high SS. Conclusion. CPB patients were in more severe ischemia baseline than OPCAB group and IMA rose in
CPB patients immediately after the surgery end, but not later. Also, the antioxidant status was significantly lower, whereas the
prooxidant status was significantly higher in patients with high SS compared to corresponding groups. SOD activity, IMA, and
TAS level were the best predictors of CAD (as determined with SS), showing that SOD and IMA had very good discriminatory
capability towards higher SS status.
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1. Introduction
It is well known that cardiovascular disease is the leading
cause of increased morbidity and mortality worldwide. One
of the key surgical procedures that patients with coronary
artery disease (CAD) are often subjected to is coronary artery
bypass grafting (CABG). However, the cardiopulmonary
bypass (CPB) pump increases systemic oxidative stress
(OS) and often leads to postoperative complications [1, 2].
This is related to ischemia and harmful effects of extracorpo-
real circulation (ECC) which induce free radical generation
production. Additionally, OS becomes more pronounced
during reperfusion followed by the end of the cardioplegic
arrest [1–3].
Therefore, attempts have been made to avoid the CPB
deleterious effects and ischemia-reperfusion injury and to
reduce the postoperative complications [4] questioning if
off-pump coronary artery bypass grafting (OPCAB) on the
beating heart may lead to diminishing the OS [5] and reduce
the rate of morbidity and mortality compared with conven-
tional on-pump CABG (i.e., CPB) [6, 7]. However, these data
are inconclusive since other studies report the opposite
results [8, 9].
Indeed, we have previously shown that patients who
underwent CPB exhibited increased OS (i.e., higher levels of
lipid hydroperoxides and advanced oxidation protein prod-
ucts), as compared with patients that underwent OPCAB
during the postoperative period [10].
The pathophysiological trait of the relationship between
OS and CABG has not been clearly elucidated. Namely, pre-
vious studies have evaluated different prooxidant and antiox-
idant parameters and different study intervals before and
after the surgical procedures [1, 10–13], but discordant
results were shown.
In an attempt to overcome the knowledge gap between
CABG procedure and the changes in redox homeostasis sys-
tem, we aimed to explore a wide spectrum of OS parameters
through the predefined study times caused by the two differ-
ent surgical procedures, i.e., CPB or OPCAB, which might
add contribution to make a proper choice of adequate surgi-
cal technique.
In addition, to obtain deeper insight into the relation-
ship between vessel wall lesion complexity and redox status,
we evaluated OS status parameters in specific study times
according to SYNTAX (synergy between percutaneous coro-
nary intervention with taxus and cardiac surgery) score (SS),
an established angiographic score for evaluation the extensity
and severity of CAD [14].
2. Patients and Methods
2.1. Patients. The current prospective cohort study was con-
ducted at the Medical Military Academy, Belgrade (Depart-
ment for Cardiac Surgery), in cooperation with the Faculty
of Pharmacy, University of Belgrade (Department for Medi-
cal Biochemistry). After approval of the Institutional Ethics
Committee (number: 29/II-27), each patient before inclusion
in the study provided the written informed consent. Detailed
methodology was described elsewhere [10]. In brief, a total of
107 patients were consecutively recruited for CABG. The
indications for surgery and patients with stable angina pec-
toris were selected according to guidelines for CABG Surgery
(American College Of Cardiology/American Heart Associa-
tion Task Force on Practice Guidelines).
The two groups of patients were formed. A total of 47
patients were included in the group where examinees under-
went CABG on the beating-heart without using CPB (i.e.,
off-pump coronary artery bypass grafting-OPCAB), whereas
a total of 60 patients encompassed the group undergoing
CABG using CPB on the potassium arrested heart (i.e., on-
pump coronary artery bypass grafting-CPB).
Patients with metabolic diseases (other than diabetes
mellitus), recent myocardial infarction or perioperative myo-
cardial infarction, unstable angina pectoris, heart failure,
mediastinal bleeding, massive postoperative and previous
stroke or transient ischemic attack, reoperation, chronic
renal failure, malignant or autoimmune diseases, acute infec-
tions, and use of immunosuppressive drugs and dietary sup-
plements were excluded from this study.
Preoperatively, the SS [14] was calculated for each
patient. SS is widely used for prediction events following
percutaneous coronary intervention. In line with this, all
patients were divided into low (i.e., SS < 22), moderate (i.e.,
SS between 22 and 30) and high SS subgroup (i.e., SS > 30).
Clinical SYNTAX score (CSS) was also calculated [15].
This score includes age, ejection fraction, and creatinine
clearance and should better predict the complexity of
patients status than SS alone, which is rather anatomical
measure of lesion complexity. By adding CSS calculation,
we got better evidence about overall functionality of CAD
patients, i.e., some critical functions, like renal function,
affected by the main disease.
Two-dimensional transthoracic echocardiography using
biplane modified Simpson method was applied as the most
commonly used diagnostic procedure to assess left ventricu-
lar ejection fraction (LVEF) clinically.
The EuroSCORE II [16] was developed to predict in-
hospital mortality after cardiac surgery and includes the
following risk factors: dyspnea, angina, extracardiac arterio-
pathy, poor mobility, previous cardiac surgery, renal dys-
function, active endocarditis, critical preoperative state, LV
function or LVEF, urgency of procedure, and recent myocar-
dial infarction.
2.2. Anesthesia. A standardized anesthetic technique was
applied to all patients which was induced by (1mg/kg) sufen-
tanyl (0.5–1μg/kg) and etomidate (0.1–0.2mg/kg). General
anesthesia was maintained with sufentanyl (0.5–1μg/kg/h)
and sevoflurane (0.6–1.0%).
2.3. Surgical Procedure. A procedure of midline sternotomy
and harvesting of left internal mammary artery as a pedicle
and saphenous vein grafts was performed and was followed
by full exposure of the coronary artery branches for
revascularization.
2.3.1. CPB Group. A procedure of ascending aortic cannula-
tion and two-stage venous cannulation in the right atrium
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was instituted for CABG using a CPB pump. A low-prime
oxygenator with an incorporated cardiotomy reservoir (Sorin
Inspire 8, Sorin Group, Mirandola, Italy) and a roller pump
(Stockert-S5, Sorin Group, Munich, Germany) were used
for CPB circuit.
The perfusion pressure between 50 and 80mmHg and
the nonpulsatile pump flow at 2.2-2.4 L/min/m2 were main-
tained during CPB. The protection of miocardium was
maintained with 4°C homemade cold potassium cardiople-
gia. All distal anastomoses of the bypass grafts were done
on the arrested heart.
2.3.2. OPCAB Group. The Octopus® IV Tissue Stabilizer and
Starfish™ 2 Heart Positioner (Medtronic, Inc., Minneapolis,
MN, USA) was used for the maintenance of mechanical
stability of the coronary arteriotomy area.
Soft plastic intraluminally coronary flow-shunt (Medtro-
nic, Clearview®, Medtronic, Inc., Minneapolis, MN, USA)
was used for myocardial protection. It was always passed into
the coronary arteriotomy to prevent the ischemia of myocar-
dium during placement of distal anastomosis. All of the
anastomoses were done on the beating heart.
2.4. Sample Collection and Analyses. The venipuncture was
performed at 6 time intervals: before surgery (t1), immedi-
ately after intervention (t2), 6 h (t3), 24 h (t4), 48 h (t5), and
96 h after termination of the operation (t6).
This procedure was the same for OPCAB and CPB group.
The central venous line from the jugular internal vein was
used for such purpose. The K2EDTA sample tubes (for
plasma) and serum sample tubes were provided. The serum
samples were left to clot for 30 minutes and then sera were
obtained by centrifugation 3000 rpm for 15 minutes and kept
at −80°C, until analysis. The plasma samples were provided
after centrifugation of samples in K2EDTA tubes 3000 rpm
at room temperature for 15 minutes and kept at −80°C, until
analysis.
2.5. Measurement of Oxidative Stress (OS) Status Parameters.
All OS status parameters were determined on an ILAB 650
analyzer (Instrumentation Laboratory, Milan, Italy).
Superoxide anion was measured in plasma following the
method of Auclair and Voisin [17], as a rate of nitroblue
tetrazolium (NBT) reduction for determination of the rate
of superoxide anion generation.
Levels of prooxidant-antioxidant balance (PAB) were
determined in serum by the method of Alamdari et al. [18]
using 3,3′, 5,5′-tetramethylbenzidine as a chromo gen.
Malondialdehyde (MDA) levels were measured in serum
as a thiobarbituric acid reactive substance [19].
Superoxide-dismutase (SOD) activity was determined in
plasma according to method of Misra and Fridovich [20]
depending on the capability of the SOD to inhibit autooxida-
tion of adrenalin in alkaline medium.
Ischemia-modified albumin (IMA) was measured in
serum by method of Bar-Or et al. [21], and values are
reported as absorption units (ABSU).
Total antioxidant status (TAS) and total oxidant status
(TOS) were determined in serum with o-dianisidine [22]
and an ABTS as a chromogen [23], respectively.
Oxidative stress index (OSI) was calculated as pre-
viously described: OSI ðarbitrary unitÞ = TOS ðμmolH2O2
equivalent/LÞ/TAS ðμmol Trolox equivalent/LÞ × 100 [24].
2.6. Statistical Analysis. A SPSS statistical package (version
18.0 for Windows, SPSS, Chicago, IL, USA) was used for sta-
tistical analysis. The sample size for each group (OPCAB and
CAB) was calculated by GPower software, and chosen α level
and power were 0.05 and 0.80, respectively. We approxi-
mated partial eta squared to be small (0.05), so the effect size
f was 0.15. In addition, we approximated correlation among
repeated measures and nonsphericity correction to be 0.6
and 1, respectively. The calculated sample size was 40 for
each group. We increased that number by 15%, considering
that nonparametric tests will be used to compare some
parameters. The data are presented as mean ± standard
deviation (SD), median (interquartile range), or counts and
percentages (%). For repeated measured ANOVA, sphericity
was tested using Mauchly’s test, and Levene’s test was used
for ANOVA homogeneity of variance checking. ANOVA
repeated measures as the nonparametric Friedman test,
followed by the Wilcoxon signed-rank test, Kruskal-Wallis
nonparametric analysis of variance, followed with the
Mann-Whitney U test were used for testing the differences
between groups. A chi-square test was used for testing the
differences between categorical data. A Spearman’s correla-
tion analysis with correlation coefficient (ρ) was applied to
examine the relationships between variables. For estimation
of clinical and general factors that could influence SS value
a logistic regression model of integrated parameters (t1-t6
study times) was applied. We used logistic regression analysis
to determine the predicted probabilities of each model
formed from redox parameters measured in different time
points for further receiver-operating characteristic (ROC)
analysis. Accuracy of each logistic model was calculated for
discrimination high from low SS patients. In all analyses, a
p value <0.05 was regarded to be statistically significant.
3. Results
Regarding SYNTAX Score subgroups, patients did not differ
by age, body weight, body mass index (BMI), LVEF, and
EuroSCORE-Logistic index. They did not also differ in
glucose, creatinine, total proteins, eGFR and hematologic
parameters ((white blood cell count (WBC), red blood cell
count (RBC), hemoglobin (Hgb), and platelet count (PLT)),
therapy usage, and percentage of smokers. Patients with
higher SS values had significantly higher extracorporal circu-
lation time (ECC) and aortic cross clamp time (ACC), so as
the average bypass number (Table 1).
The several main characteristics of CPB procedure such
as aortic cross clamp time (ACC) and extracorporal circula-
tion time (ECC) are significantly higher in patients with
higher SS, which implies the more complicated artery lesion
condition in patients subjected to this procedure. We have
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also calculated CSS. With SS increase, we have also found sig-
nificant CSS increase (Table 1).
The OS status parameters change through the predefined
study times according to implemented surgical technique
(i.e., CPB or OPCAB) are presented in Figure 1.
TOS decreased in both study groups, compared to
baseline values, but this decrease did not reach statistical sig-
nificance. TOS values were higher in OPCAB compared to
CPB group in several study points.
Superoxide anion showed significant increase in t3-t6
study times, in CPB, so as in OPCAB group, with comparable
values in both study groups, and the highest values at t6 study
point. Similar way of increase has also seen for PAB parame-
ter. MDA significantly increased only in CPB group in t5 and
t6 interval. MDA was significantly higher in CPB group com-
pared to OPCAB in t6 study point.
CPB patients had significantly lower TAS compared to
OPCAB patients at the beginning and also in t2 and t3
study points. In CPB, we noticed the initial decrease in
TAS values, then sharp increase and decrease till the end
of the study period. In OPCAB, we found initial increase
in TAS and from the t3 (24 h after the surgery end), signifi-
cant decrease compared to baseline value. CPB patients had
significantly lower SOD activities compared to OPCAB,
baseline, and in several study points, when SOD increased
in OPCAB patients.
CPB patients had higher IMA baseline than OPCAB
group. Initially, IMA rose in CPB, in t2 point, and after that
we could not report any significant change in this parameter
till the study end.
Parameters in specific study times, which showed signif-
icant difference according to SS level (i.e., low, intermediate,
and high SS subgroups) are presented at the Table 2.
It is clear that TAS level is significantly lower in patients
with high SS level, baseline so as in the first two study times
(till 24 h). Also, SOD decrease along with SS increase was
obvious, so as TAS/TOS ratio, which is also representative
of antioxidative potential. Unexpectedly, TOS was also lower
in high SS group of patients. PAB was significantly higher in
patients with high SS compared to low and moderate groups.
OSI index (TOS/TAS ratio) was also higher in high SS group
than in low and moderate groups.
Table 1: General clinical and surgery related parameters according to SYNTAX Score tertile values.
Parameter Low SS < 22 (15:6 ± 4:8) Moderate SS 22-32 (27:1 ± 3:2) High SS > 32 (38:6 ± 6:1) P
n 34 39 33 /
Age (years) 63:2 ± 9:6 62:2 ± 9:4 67 ± 9:1 ns
Body weight (kg) 81:1 ± 12:7 81:1 ± 10:2 84:4 ± 14:5 ns
BMI (kg/m2) 27:7 ± 3:1 27:6 ± 3:4 28:8 ± 4:4 ns
sGlucose (mmol/L) 6:40 ± 2:02 6:34 ± 2:12 6:77 ± 2:55 ns
sCreatinine (μmol/L) 85:1 ± 25:8 95:0 ± 58:1 89:5 ± 27:7 ns
sTotal proteins (g/L) 71:2 ± 5:1 71:0 ± 5:4 70:8 ± 4:8 ns
eGFR (mL/min/1.73m2) 83:6 ± 21:4 83:0 ± 26:1 79:1 ± 20:1 ns
WBC (×109/L) 7:0 ± 1:8 6:9 ± 1:6 7:1 ± 1:8 ns
RBC (×1012/L) 4:6 ± 0:5 4:6 ± 0:5 4:6 ± 0:6 ns
Hgb (g/L) 134 ± 14 136 ± 14 135 ± 12 ns
PLT (×109/L) 230 ± 60 233 ± 52 220 ± 69 ns
LVEF (%) 52:0 ± 8:7 50:0 ± 9:9 47:6 ± 10:9 ns
EuroSCORE-logistic 5 (3-8.25) 5 (3-7) 7 (5-10) ns
Clinical SS 19.1 (13.3-29.1) 33.6 (26.6-43.8)aaa 50.4 (43.8-81.2)aaa,bbb <0.001
ECC (min) 0 (0-0) 72 (0-87)aa 81 (72.8-114.5)aaa,bb <0.001
ACC (min) 0 (0-0) 29 (0.0-49)aa 44 (36-56)aaa,bb <0.001
Bypass number 2:06 ± 0:49 2:33 ± 0:54 2:59 ± 0:64a <0.05
β-Blockers, n (%) 30 (88.2%) 38 (97.4%) 33 (100.0%) 0.055
ACE inhibitors, n (%) 27 (79.4%) 37 (94.9%) 29 (87.9%) ns
Calcium-antagonists, n (%) 11 (32.4%) 13 (33.3%) 12 (36.4%) ns
Nitrates, n (%) 29 (85.3%) 34 (87.2%) 32 (97.0%) ns
Statins, n (%) 22 (64.7%) 30 (76.9%) 24 (72.7%) ns
Oral antidiabetics, n (%) 8 (23.5%) 5 (12.8%) 8 (24.2%) ns
Diuretics, n (%) 10 (29.4%) 9 (23.1%) 16 (48.5%) ns
Smokers, n (%) 23 (67.6%) 30 (76.9%) 22 (66.7%) ns
BMI: body mass index; LVEF: left ventricular ejection fraction; ECC: extracorporal circulation time; ACC: aortic cross clamp time; P: ANOVA or Kruskall-
Wallis nonparametric analysis of variance; Tuckey-Snedecor post hoc test. a,aa,aaa: P < 0:05, 0.01, 0.001 vs. low SS group; bbP < 0:01 vs. moderate SS group.















































































































Figure 1: Dynamics of oxidative stress parameters’ changes in CABG, precisely two surgery types, i.e., CPB and OPCAB before surgery
and after the procedure in defined study points. (a) Total oxidative status (sTOS), (b) superoxide anion (pO2
.–), (c) prooxidative-
antioxidative balance (sPAB), (d) malondyaldehide (sMDA), (e) total antioxidative status (sTAS), and (f) superoxide-dismutase (pSOD).
∗, ∗∗, ∗∗∗P < 0:05; 0.01; 0.001 OPCAB vs. the same time point in CPB group. a, aa, aaaP < 0:05; 0.01; 0.001 in CPB group (t2-t5) vs.
baseline. b, bb, bbbP < 0:05; 0.01; 0.001 in OPCAB group (t2-t5) vs. baseline. s: serum; p: plasma.
Table 2: Oxidative stress status parameters according to SYNTAX Score tertile values in different study times depending on significant
change through SS subgroups.
Parameter Low SS < 22 (15:6 ± 4:8) Moderate SS 22-32 (27:1 ± 3:2) High SS > 32 (38:6 ± 6:1) P
sTAS t1 (μmol/L) 497 (331-564) 393 (157-689) 247 (113-370)aa <0.05
sTAS t2 (μmol/L) 476 (261-653) 238 (206-575) 166 (2.00-290)aaa,bb <0.01
sTAS t3 (μmol/L) 568 (438-638) 617 (434-727) 357 (220-526)aa,bb <0.01
sTOS t3 (μmol/L) 26.4 (20.5-32.7) 18.3 (15.6-22.9)a 15.1 (12.5-23.0)aa,b <0.05
sTOS t4 (μmol/L) 20.8 (17.4-24.9) 17.7 (14.3-20.5) 16.7 (10.8-22.6)a <0.05
pSOD t5 (U/L) 144 (120-156) 121 (60-135)a 111 (76-122)aa <0.05
sPAB t5 (U/L) 125 (115-145) 118 (107-136) 145 (125-179)a,b <0.05
TAS/TOS t2 20.3 (9.5-28.0) 14.0 (7.8-30.6) 7.3 (0.1-13.7)aa,bb <0.05
OSI index t2 0.05 (0.04-0.11) 0.07 (0.03-0.13) 0.14 (0.07-7.87)aa,bb <0.01
P: Kruskall-Wallis test, a,aa,aaaP < 0:05; 0.01; 0.001, respectively, vs. low SS group (<22 points), Mann-Whitney U test; b,bb,P < 0:05; 0.01, respectively, vs.
moderate SS (22-32 points), Mann-Whitney U test; s: serum; p: plasma.
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Correlation analysis of OS status parameters and SS value
showed that TAS and TOS parameters had significant nega-
tive correlation with SS level for the most study point times.
SOD also showed significant inverse correlation with SS
level. PAB 48h after the surgery showed positive correlation
with SS level. Both results are expected having in mind OS
parameters nature (Table 3).
Correlation in subgroups according to SS level showed
the following: significant negative correlation between IMA
and SS in Low SS group, positive TAS correlation in moder-
ate SS group and negative correlation in high SS group, and
positive MDA correlation with SS level in high SS group
(Table 4).
ROC analysis was performed to find the most significant
predictors of SS level (low vs. high SS subgroups). Using
logistic regression analysis for integrated OS status parameter
models generation, the best SS level predictors were SOD
activity, IMA, and TAS level (Figure 2).
Logistic regression analysis showed that SOD and IMA
had very good discriminatory capability (AUC = 0:840 and
AUC = 0:813, respectively) [25].
Out of 107 CABG patients included in the current study,
a total of 3 postoperative complications were noted in the
OPCAB group, and 12 in the CPB group and the most
prominent ones were leg wound infection, pleural effusion,
pulmonary thromboembolism, and shallow sternal wound
infection.
4. Discussion
To our knowledge, this is the first study that examined the
broad spectrum of OS biomarkers in patients undergoing
CABG in relation to different surgery modalities. Several
important findings of the current study need to be acknowl-
edged. According to the main aim of this project, we have
followed OS status parameters (i.e., IMA, MDA, superoxide
anion, PAB, TOS, TAS, and SOD) change through the prede-
fined study times to obtain deeper knowledge into the redox
homeostasis before and after CABG intervention. We have
also analyzed the difference in OS generation caused by the
two different surgical procedures, i.e., CPB or OPCAB and
found that CPB patients were in more severe ischemia (as
measured with IMA) baseline than OPCAB group. Further-
more, IMA rose in CPB patients immediately after the
surgery end and after that no significant change in this
parameter was observed.
Following the change of OS status parameters before and
after the surgical intervention in CPB and OPCAB group, we
have observed the decrease (but without statistical signifi-
cance) in TOS in both study groups, compared to the levels
before the operation. We have shown that TOS levels, as a
measure of peroxide generation [23], were lower in CPB
compared to OPCAB group in several study points. It seems
that dynamics of this parameter change was not compatible
with our study times. Precisely, peroxides generation is prob-
ably the fast process, and this kind of reactive species are sub-
jected to rapid decomposition, during the surgical procedure,
i.e., the times which we did not include in this study.
After the initial decrease, superoxide anion showed sig-
nificant increase in other study times in both, OPCAB and
CPB group, exhibiting the highest levels at the end of the
observed period. Similar way of increase was also seen for
PAB. MDA significantly increased only in CPB group
towards the end of the observed period. MDA is a marker
of late peroxidation phase [19], and we have shown that it
was significantly higher in CPB group compared to OPCAB
in 96th h after the surgery completion.
CPB patients had significantly lower TAS levels com-
pared to OPCAB patients at the beginning and also 6 h after
intervention. CPB patients had significantly lower SOD
activities compared to OPCAB, baseline, and in several study
points, when SOD increased in OPCAB patients. SOD
dynamics was interesting and could be analyzed with the
changes of other oxidative status factors, primarily with
superoxide anion dynamics, which is a substrate for SOD
enzymatic activity [20].
Luyten et al. [26] found an increase in SOD activity,
which returned to the baseline values 24h after the surgical
Table 3: Spearman’s nonparametric correlation between SYNTAX
Score value and OS status parameters.
OSS parameter SYNTAX score
sTAS, μmol/L t1 -0.318∗
sTAS, μmol/L t2 -0.417∗∗∗
sTAS, μmol/L t3 -0.249∗
sTAS, μmol/L t6 -0.259∗
sTOS, μmol/L t1 -0.259∗
sTOS, μmol/L t3 -0.418∗∗
sTOS, μmol/L t4 -0.331∗∗
sTOS, μmol/L t5 -0.298∗
sTOS, μmol/L t6 -0.247∗
pSOD, U/L t3 -0.310∗
pSOD, U/L t5 -0.368∗∗
sPAB, U/L t5 0.256∗
Data were shown with (ρ)-Spearman’s correlation coefficient. ∗ ,∗∗P < 0:05,
0.01, respectively, are only for the significant correlation between SS and
OS status parameters in different study times; s: serum; p: plasma.
Table 4: Spearman’s nonparametric correlation in SYNTAX Score
subgroups (SS < 22, SS 22-32, SS > 32).
Parameter, study time Low SS < 22 Moderate SS
(22-32)
High SS > 32
sIMA, ABSU t4 -0.460∗ / /
sIMA, ABSU t5 -0.455∗ / /
sTAS, μmol/L t3 / 0.474∗ /
sTAS, μmol/L t4 / / -0.526∗
sMDA, μmol/L t1 / / 0.551∗
Data were shown with (ρ)-Spearman’s correlation coefficient. ∗P < 0:05 for
the significant correlation between SS and OS status parameters in SS level
subgroups. s: serum.
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procedure. At the same time in the mentioned study, the
authors reported huge increase of the total antioxidant
capacity of 60%. In our current study, antioxidants (enzy-
matic and nonenzymatic) showed also initial increase and
then decrease till the study end (96 h).
In our previous study, we have recorded higher levels of
lipid hydroperoxides and advanced oxidation protein prod-
ucts in the CPB, as compared with OPCAB group during
the postoperative period, showing that OS was higher in the
CPB group which could be attributed to more harmful condi-
tions of the CPB patients or their diminished ability to
respond to the OS threat [10].
By measuring IMA, we aimed to follow up changes in
ischemic condition in CAD patients. Initially, IMA has
increased after the surgery in our group of patients, but ear-
lier in CPB compared to OPCAB patients (Figure 3). Kanko
et al. [13] also found significantly increased IMA values in a
group of CPB patients. Taking into account that IMA is a
marker of the early myocardial ischemia, we assumed that
IMA measurement is worthwhile in cardiovascular bypass
surgery settings. Thus, IMA measurement could contribute
to the earlier treatment and better follow-up of the CABG
patients. According to Bar-Or et al. [21], a value of 0.400
ABSU represents the cut-off point which delineates ischemic
condition. It was obvious that our patients’ values were far
above 0.400 ABSU in the whole course of the observed
period, suggesting that examined CAD patients were in
chronic ischemia state, which was more pronounced in
CPB compared to OPCAB patients. Ischemia may lead to
increased production of reactive oxygen species and conse-
quent modification of albumin. These processes result in an
increased IMA formation, which was shown to be a reliable
marker in detection of the early stages of ischemia, before
the occurrence of necrosis [13].
In order to get better insight into the relationship
between vessel wall lesion complexity and redox status, we
have divided study patients at low, moderate, and high SS
subgroups and compared OS status parameters in specific
study times. Namely, it was previously shown that patients
with SS above 22 (boundary between low and moderate
atherosclerotic lesion) according to the results of Syntax
score study [14] should be subjected exclusively to CABG
surgery in order to avoid adverse cardiovascular events and
need for revascularization. The several main characteristics
of CPB procedure, such as aortic cross clamp time (ACC)
and extracorporal circulation time (ECC), were significantly
higher in patients with higher SS, which implies the more
complicated artery lesion condition in patients subjected to
this procedure. With SS increase, we have also found signifi-
cant CSS increase, which suggests general worsening of
patients’ systemic condition as a consequence of advanced
atherosclerosis (Table 1).
Additionally, we revealed that the antioxidative potential
(i.e., TAS, SOD, and TAS/TOS ratio) was significantly lower,
whereas parameters that show OS balance (i.e., PAB and OSI
index) were significantly higher in patients with high SS com-
pared to low and intermediate SS group. Unexpectedly, TOS
was also lower in high SS group of patients, and this finding
should be subjected to further analysis.
Thereafter, ROC analysis was performed to find the most
significant predictors of SS level (low vs. high SS subgroups).
Using logistic regression analysis for OS status parameter
generation, the best SS level predictors were SOD activity,
IMA, and TAS level. SOD and IMA showed very good dis-
criminatory capability towards higher SS status.
Antioxidant capacity has previously been recorded as
a predictive marker in determining postoperative compli-
cations [12].
The CPB technique is a main reason for ischemia-
reperfusion which causes the release of superoxide anion,
primarily by the xanthine oxidase (XO) system [27].
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Figure 2: ROC analysis of different OSS parameters as SYNTAX
Score value predictors. AUC (SE): area under the curve (standard
error); 95th CI (confidence interval); P: significance. Logistic
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Figure 3: Ischemia-modified albumin (sIMA) concentration in
CABG subjects and according the two surgery types (CPB and
OPCAB) before surgery (t1) and after the procedure (t2-t6). ∗, ∗∗,
P < 0:05; 0.01 OPCAB vs. the same time point in CPB group;
s: serum.
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Products of purine bases (hypoxanthine and xanthine)
accumulate in ischemic tissues, and XO was suggested to be
a key source of reactive oxygen species (ROS) during ische-
mia/reperfusion. With the onset of ischemic state, the accu-
mulation of hypoxanthine produced via the catabolism of
ATP, and a consequent conversion of xanthine dehydroge-
nase (XDH) to XO occurs, which is the key source of ROS
[28]. Along with the reperfusion process, it is assumed that
oxygen and accumulated hypoxanthine react with XO
leading to increased production of superoxide anion [27].
In addition, treatments with allopurinol and SOD were
shown to be efficient in attenuating the response of vascular
permeability induced by ischemia/reperfusion process, thus
suggesting that XO-derived superoxide, a substrate for SOD
enzymatic activity [20], was involved in the endothelial dys-
function [27].
Despite the fact that we have included a wide spectrum of
parameters of redox homeostasis in this study, we should
mention its several drawbacks. The limitation of the current
study lies in the fact that it included a relatively small number
of patients, and all measurements of oxidative stress param-
eters were performed once. However, this is the standard
procedure for determination of oxidative stress parameters
because all methods are validated, the calibration was per-
formed, and the reliability of results and the quality control
are maintained by measuring normal and abnormal control
material before analyses.
We were also limited for determination of lipid metabo-
lism parameters which may affect the results of the study
[29, 30]. Moreover, we were not able to exclude type 2 diabe-
tes, smoking, and medications other than immunosuppres-
sive drugs and dietary supplements, which all might affect
the results of the study. In addition, a control group of
healthy subjects could have been useful to compare the base-
line oxidative stress status parameters with the study group.
Also, this is a single-center study. Therefore, new multicenter
studies with larger sample size and with control group
included would be of benefit to better evaluate the role of oxi-
dative stress in the mentioned pathology and to validate our
results.
5. Conclusion
The results of the current study revealed that patients with
high SS exhibited pronounced redox imbalance reflected by
increased prooxidant species, while reduced antioxidant ele-
ments compared to patients with low and intermediate SS.
Additionally, two redox status opposite features, both with
protein nature, i.e., one important enzymatic antioxidant
(SOD) and the other product of oxidative stress burden
(IMA), could predict CAD severity and complexity, deter-
mined as SS values. This study adds information about more
severe ischemic condition of CPB patient baseline compared
with OPCAB group, and also, we got insight into severe
ischemia development in the CPB patients after the surgery.
Importantly, this ischemia did not persist in subsequent
study points, which is encouraging having in mind worse
condition of these patients compared to OPCAB ones.
Taking all these into account, further investigation of
redox status parameters would be of great importance in
different cardiac surgery modalities which might enable to
reduce the deleterious effects of these procedures, by inclu-
sion of some preoperative and/or postoperative antioxidants
as supportive therapy.
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